Organization and Nature of Business - Additional Information (Details) $ / shares in Units, $ in Thousands			12 Months Ended
	Oct. 08, 2021 USD ($) $ / shares shares	Oct. 01, 2021	Dec. 31, 2021 USD ($) Segment $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2019 shares
Subsidiary, Sale of Stock [Line Items]
Number of operating segment | Segment			1
Number of reportable segment | Segment			1
Reverse stock split, conversion ratio		0.15725743
Net proceeds from issuance initial public offering			$ 152,296
Capital stock authorized | shares	200,000,000
Common stock, shares authorized | shares	190,000,000		190,000,000	40,300,000
Preferred stock, shares authorized | shares	10,000,000		10,000,000	0
Common stock, par value per share | $ / shares	$ 0.001		$ 0.001	$ 0.001
Preferred stock, par value per share | $ / shares	$ 0.001		$ 0.001	$ 0.001
Accumulated deficit			$ (91,718)	$ (15,743)
Net loss			(75,975)	(12,828)
Cash and cash equivalents			$ 274,735	$ 8,080
Convertible Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Number of common shares issued upon conversion of preferred stock | shares	20,056,145
Convertible preferred stock, shares outstanding | shares			0	22,724,925	22,724,925
Common Stock
Subsidiary, Sale of Stock [Line Items]
Stock issued | shares				49,061
Gross proceeds from issuance of initial public offering	$ 168,000
Net proceeds from issuance initial public offering	$ 152,300
Initial Public Offering | Common Stock
Subsidiary, Sale of Stock [Line Items]
Stock issued | shares	10,500,000		10,500,000
Common stock public offering price per share | $ / shares	$ 16.00
Underwriting discounts and commissions	$ 11,800
Stock issuance expenses	$ 3,900